# Technical Feasibility Analysis - Rapid Gene Cloning

## Approach Details
REFINED HYPOTHESIS: Integrate assembly + cell-free functional expression + inline nanopore sequence verification in a single same-day workflow. The novel element is closing the loop on sequence verification without bacteria.

## Feasibility Assessment
- Assembly (Gibson/Golden Gate): mature, works in vitro ✓
- RCA amplification (phi29): proven for cell-free cloning ✓
- Cell-free TX-TL: mature, 4+ mg/mL protein possible ✓
- Nanopore sequencing of amplified products: DuBA.flow showed <€0.10/sample ✓
- **Integration**: No one has combined all four steps into a unified protocol. This is the gap.

## Proposed Workflow
1. Golden Gate assembly of parts (1 hour)
2. Phi29 RCA to amplify circular product (2 hours)
3. Nanopore sequencing of RCA product for sequence confirmation (1 hour)
4. Cell-free TX-TL of verified construct for functional validation (4 hours)
**Total: ~8 hours, same-day, no bacteria.**

## Cost Estimate
- Assembly enzymes: ~$5
- Phi29 RCA: ~$3
- Nanopore flow cell (amortized per sample with multiplexing): ~$5-10
- Cell-free extract: ~$10-20
- **Total: ~$25-40 per construct** (competitive with bacterial cloning)

## Risk Analysis
- RCA concatamers may not be ideal for nanopore QC (could address with restriction digestion before sequencing)
- Cell-free TX-TL from RCA product has been shown but not extensively characterized
- Nanopore sequencing requires library prep that adds time/complexity

## Originality Score: 6/10 (individual pieces exist, but integrated workflow is novel)
## Tractability Score: 8/10 (all components exist, integration is engineering challenge)
